PetVivo’s SPRYNG® with OsteoCushion® a cutting-edge solution for animals suffering from joint-related issues like osteoarthritis and joint instability

·         PetVivo’s SPRYNG® with OsteoCushion® a cutting-edge solution for animals suffering from joint-related issues like osteoarthritis and joint instability. The technology behind SPRYNG®, with its intra-articular injectable design and extracellular matrix microparticles, seems promising for promoting joint health and reducing pain. These microparticles appear to work by integrating with the animal’s subsynovial tissue, which could help restore proper joint mechanics.

·         PetVivo also plans to showcase its innovative product, PrecisePRP®, a first-of-its-kind off-the-shelf platelet-rich plasma (PRP) solution designed for veterinary use. PrecisePRP is a leucoreduced, allogeneic, pooled, freeze-dried PRP that offers a species-specific source of concentrated platelets in plasma, intended for intra-articular injection in dogs and horses. Unlike other PRP kits available, PrecisePRP doesn’t require blood collection or centrifugation, making it a truly ready-to-use product that is both convenient and simple. What sets PrecisePRP apart is its consistency and uniformity—each vial contains a precise dose of 4 billion platelets, with a concentration of 500,000 platelets per microliter and fewer than 1,500 white blood cells per microliter.

·         PetVivo has formed a transformative strategic partnership with Digital Landia Corp., a trailblazer in Agentic AI technology. The collaboration revolves around Pet AI, Digital Landia’s groundbreaking open-source platform that interprets animal behavior by analyzing vocalizations, body language, and physiological signals in real time through smartphone cameras. This technology, which boasts 97% accuracy in decoding animal communication, will integrate PetVivo’s veterinary products into an innovative global pet care ecosystem.